A point-of-care device clears clinical validation. The hardware performs exactly as specified. The ML model is genuinely accurate. And then, weeks after deployment, usage drops. Not because the technology failed, but because the interface asked too much of the people using it.

This is alarm fatigue. And it is one of the most underestimated barriers to commercial success in digital health.

Why this matters now

Alarm fatigue is not a new problem: it has been documented in hospital settings for years. What is new is the scale at which it is now relevant. As point-of-caredevices move toward continuous monitoring, they generate exactly the kind of dense, high-frequency data streams that overwhelm static alert systems.

A 2025 review of AI-driven POC sensor systems published in Biosensors (MDPI)identifies the key UX barriers to clinical adoption:

• High cognitive load from poorly filtered alert systems
• Poor UI/UX that disrupts clinical workflows rather than supporting them
• Opaque ML outputs that hinder clinical acceptance

The same review points to explainable ML – providing context and confidence scores alongside alerts – as one of the most effective tools for addressing these barriers. The technology to solve the problem exists. Whether it gets applied depends on design decisions made early in the product cycle.

The real cost of alarm fatigue in point-of-care devices

POC devices are designed for high sensitivity: the side effect is a constant stream of alerts, most of which require no action. Clinicians adapt quickly: they learn that most notifications can safely be ignored, and they start treating them accordingly.

The problem is that this habit does not stay selective. Once the threshold for ignoring alerts drops, legitimate warnings get missed alongside the noise. For point-of-care devices, where the value proposition is continuous monitoring, this is not a peripheral concern. It is the central adoption risk.

Strategy 1: Alerts that adapt to the individual

The most direct response to alarm fatigue is making alerts smarter: not just more sensitive, but more selective and contextualised.

Smart cardiac monitoring platforms can individualise alert thresholds and risk stratification criteria based on:

• A patient's prior arrhythmic history
• Patient-specific signal features
• Real-time contextual data

The design shift is from static population-level thresholds to dynamic, patient-level baselines. ML models that learn from longitudinal individual data, rather than applying fixed rules across all users, are what make this possible.

This is also where explainability earns its place in medical device UX. An alert that tells a clinician not just what it detected, but how confident the model is and why it triggered, is one that gets evaluated rather than dismissed.

The alerting layer needs to be treated as a first-class design problem from day one, not a default configuration to be adjusted post-deployment.

Strategy 2: Automation that works silently

Not every insight a point-of-care device generates needs to become a notification. Some of the most valuable things a well-designed system can do are invisible to the user: data logged, quality checked, routed, and processed without requiring any active decision.

This is automation and workflow optimisation: ML pipelines that handle signal calibration, artifact filtering, and anomaly detection in the background.

KardiaMobile, the pocket ECG device developed by AliveCor, applies this principle directly. Its ML pipeline works continuously in the background to:

• Classify ECG signals automatically
• Filter noise and artifacts without user input
• Surface only the events that meet the threshold for clinical relevance

The user sees a clean result. The processing that produced it stays out of the way.

Reducing cognitive load does not always mean simplifying what the system does: sometimes it means keeping complexity out of sight entirely.

Strategy 3: Design that fits the clinical workflow

The third strategy asks a different kind of question: where does this product actually live in the clinical day? What was the user doing before they picked itup, and what do they need to do immediately after? Devices designed as standalone tools, rather than as components of an existing workflow, create friction even when they perform well technically.

Swift Medical's wound assessment platform shows what happens when you take workflow seriously from the start. The system uses computer vision and ML to analyse wound images and sensor data. Its clinical impact is measured not just in diagnostic accuracy, but in workflow metrics:

• Clinicians completed assessments nearly 79% faster
• First-attempt success rates for high-quality images rose from 75.7% to 92.2%
• The system saves one to two minutes per assessment

These are not marginal gains. They are the difference between a tool that fits into a clinical day and one that adds to it.

The adoption problem is a design problem

Alert fatigue is a symptom. The root cause is a design process that treats UX as a finishing layer, something addressed after sensor performance is validated, rather than alongside it.

The devices that succeed commercially are not necessarily the most accurate ones. They are the ones that clinicians and patients keep using.

The question worth asking at the start of every product cycle is not only whether the point-of-care device performs accurately, but whether the people who need to use it will actually use it day after day, under real clinical conditions, without support.

The answer is almost entirely determined by software and interface decisions.
Which means it is also entirely within reach.

‍

‍

At Aimasoft, we work with medtech companies to close exactly this gap: betweendevices that perform and devices that get used. If your product is technicallysound but struggling with adoption, the interface is almost certainly where theanswer lies.